Medicines A–Z
C
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Clobazam tablets | MHRA Category 2: the need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history |
|
|
Clobetasol propionate 0.05% cream | Very potent |
|
|
Clobetasol propionate 0.05% ointment | Very potent |
|
|
Clobetasol propionate 0.05% scalp application | Very potent |
|
 |
Clobetasone butyrate 0.05% cream | Moderate potency |
|
|
Clobetasone butyrate 0.05% ointment | Moderate potency |
|
 |
Clofarabine injection | For hospital use only |
|
|
Clomifene tablets | Specialist recommendation - ovulation induction |
|
|
Clomipramine capsules | Specialist initiation only |
|
|
Clonazepam injection | MHRA Category 2: the need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
